Skip to main content
OpenTrials
Completed

NCT Number: NCT02105922

Effect of Strength Training and Protein Ingestion in Old Versus Very-old

From 3 interventiongroups in the project with ClinicalTrials.gov ID NCT02034760, namely:

HRTW: Heavy Strength Training x3/week & 20g whey protein twice daily. LITW: Light Intensity Training x3-5/week & 20g whey protein twice daily. WHEY: 20g whey protein twice daily.

15 subjects from each group will be recruited and tested after 3 months of intervention. Tests will include muscle cross sectional area (MRi), muscle biopsies (fiber types, size, cell- and capillary count), functional- and strength measurements, plasma lipids, HbA1c. Tests are to be compared with Project ID NCT01997320.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bispbebjerg Hospital

Copenhagen NV, 2400, Denmark

About this study

In- and exclusion criteria are listed in NCT02034760. Subjects will be randomized to interventions as described, and 15 subjects from each of the three groups will be tested after 12 weeks of intervention.

15 subjects are included in each group to account for an expected drop-out rate of 20%, and so 12 subjects are expected to complete each intervention. With this N an increase of around 11% in MRi-evaluated muscle size can be detected with a powerlevel of 80% and an alpha of 0.05 and use of reported SD.

Primary outcome is muscle size (MRi), and secondary outcomes are overall body composition (DXA), muscle strength, rate of force development, power, 30s chair stand, 400m gait speed, grip strength. Tertiary outcomes are habitual activitylevel (accelerometry), blood samples (HbA1c, cholesterols, creatinine), blood pressure, weight, BMI, wast- and hip circumference.

Results are to be compared with NCT01997320 and so a population of 65+ can be compared with a population of 83+. Both studies uses the same heavy strength training regimen.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy, independently living
  • Age at least 65 years

Exclusion criteria

  • Subjects dependent on help/nursing etc.
  • Chronic medical diseases: Diabetes mellitus, clinical knee or hip osteoarthritis, other types of arthritis or connective tissue disorders, active cancer, renal diseases, severe chronic obstructive pulmonary disease, cardiac arrhythmias or known decreased left ventricular ejection fraction, lactose or gluten intolerance, chronic inflammatory bowel diseases, non-treated hyper/hypothyroidism, dementia.
  • Surgical diseases: Bone, muscle, tendon or joint injuries compromising participation in exercise regimens.
  • Implanted magnetic devices incompatible with MRi-scanning.
  • Weekly alcohol consumption > 21 units (1 unit equals 4g of ethanol) for men and > 14 for women.
  • Medicine except acetylsalicylic acid, paracetamol, thyroid function hormones, statins in doses above 40mg/day or if combined with subjective myalgia, ACE-inhibitors, Angiotensin II blockers, beta-blockers, calciumantagonists, proton-pump inhibitors, thiazides, potassium-sparing diuretics and loop diuretics.
  • >1 hour of exercise weekly, except light activities such as stretching/gymnastics and bike-riding/walking as transportation.

Treatment and study plan

Heavy Resistance Training

Procedure

Supervised Heavy Resistance Training three times weekly for 3 months.

Light Intensity Training

Procedure

Home-based Light Intensity Training three-five times weekly for 3 months.

Protein Whey

Procedure

Two daily 20g whey protein and 10g carbohydrate supplementations for 3 months.

Primary outcomes

  1. Change in muscle cross sectional area

    Time frame: Baseline, 3 months

    MRi scans of quadriceps muscle cross sectional area. The statistical evaluation of the primary outcome measure is done by applying a two way ANOVA test comparing groups: 1) Heavy Resistance Training vs. Light Intensity Training vs. Protein Whey. The statistical evaluation will be performed first as an intension-to-treat analysis and subsequently as a per-protocol analysis.

Secondary outcomes

  1. Change in quadriceps muscle isometric strength

    Time frame: Baseline, 3 months

    Isometric unilateral quadriceps force and rate of force development measured in the isokinetic dynamometer device (KinCom) during knee extension at the knee angle 70 deg (with 0 degrees being fully extended).

  2. Change in quadriceps muscle isokinetic strength

    Time frame: Baseline, 3 months

    Unilateral knee extension (concentric) strength measured in the KinCom device at an angular velocity of 60 degrees/sec.

  3. Change in leg extension muscle power

    Time frame: Baseline, 3 months

    Unilateral leg extension power measured in the Powerrig device.

  4. Change from baseline in muscle structure and signalling

    Time frame: Baseline and 3 months

    From muscle biopsies muscle fiber type distribution and size, capillary density, satellite cell count and activity, selected gene-expression targets and protein concentrations will be assessed.

  5. Change in 30 s chair stand

    Time frame: Baseline, 3 months

    Number of stand-ups from a chair in 30 seconds.

  6. Change in whole body composition and bone mineral density

    Time frame: Baseline, 3 months

    Body composition (fat mass, lean mass and bone mass) evaluated by whole-body dual energy x-ray absorptiometry (DXA)-scanning.

    Bone mineral density at dominant collum femoris and vertebrae L2-L4 evaluated by DXA-scanning.

Other outcomes

  1. Change in blood parameters and anthropometry

    Time frame: Baseline, 3 months

    Blood: HbA1c, plasma lipids. Anthropometry: Weight, abdominal circumference. Blood pressure.

  2. Change in gait speed

    Time frame: Baseline, 3 months

    400 m gait speed.

  3. Change in grip strength

    Time frame: Baseline, 3 months

    Isometric hand grip strength.

  4. Questionnaires and interviews

    Time frame: Baseline, 3 months

    Short Form 36

  5. Change in habitual activity

    Time frame: Baseline, 3 months

    Evaluated by 4 days continuous monitoring by a pedometer device (ActivPal).

  6. Change in daily macronutrient intake

    Time frame: Baseline, 1,5 months

    4-days self-report of food and beverage intake.

Sponsors and collaborators

Lead sponsor

Bispebjerg Hospital

Other

Collaborators

  • Arla Foods
  • University of Copenhagen

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Apr 7, 2014
Registry last updated
Feb 28, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.